1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)
Autor*in: |
Victoria P Werth [verfasserIn] Eric F Morand [verfasserIn] Melinda Przetak [verfasserIn] Flavie Moreau [verfasserIn] Cristina Vazquez-Mateo [verfasserIn] Andrew Bender [verfasserIn] Sanjeev Roy [verfasserIn] Aditee Deshpande [verfasserIn] Ankita Deshmukh [verfasserIn] Bharat Vaidyanathan [verfasserIn] Mukhy Khursheed [verfasserIn] David R Pearson [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Übergeordnetes Werk: |
In: Lupus Science and Medicine - BMJ Publishing Group, 2015, 9(2022), Suppl 3 |
---|---|
Übergeordnetes Werk: |
volume:9 ; year:2022 ; number:Suppl 3 |
Links: |
---|
DOI / URN: |
10.1136/lupus-2022-lupus21century.95 |
---|
Katalog-ID: |
DOAJ024830186 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ024830186 | ||
003 | DE-627 | ||
005 | 20230307081025.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/lupus-2022-lupus21century.95 |2 doi | |
035 | |a (DE-627)DOAJ024830186 | ||
035 | |a (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC581-607 | |
100 | 0 | |a Victoria P Werth |e verfasserin |4 aut | |
245 | 1 | 0 | |a 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
653 | 0 | |a Immunologic diseases. Allergy | |
700 | 0 | |a Eric F Morand |e verfasserin |4 aut | |
700 | 0 | |a Melinda Przetak |e verfasserin |4 aut | |
700 | 0 | |a Flavie Moreau |e verfasserin |4 aut | |
700 | 0 | |a Cristina Vazquez-Mateo |e verfasserin |4 aut | |
700 | 0 | |a Andrew Bender |e verfasserin |4 aut | |
700 | 0 | |a Sanjeev Roy |e verfasserin |4 aut | |
700 | 0 | |a Aditee Deshpande |e verfasserin |4 aut | |
700 | 0 | |a Ankita Deshmukh |e verfasserin |4 aut | |
700 | 0 | |a Bharat Vaidyanathan |e verfasserin |4 aut | |
700 | 0 | |a Mukhy Khursheed |e verfasserin |4 aut | |
700 | 0 | |a David R Pearson |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Lupus Science and Medicine |d BMJ Publishing Group, 2015 |g 9(2022), Suppl 3 |w (DE-627)792128222 |w (DE-600)2779620-6 |x 20538790 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2022 |g number:Suppl 3 |
856 | 4 | 0 | |u https://doi.org/10.1136/lupus-2022-lupus21century.95 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2053-8790 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 9 |j 2022 |e Suppl 3 |
author_variant |
v p w vpw e f m efm m p mp f m fm c v m cvm a b ab s r sr a d ad a d ad b v bv m k mk d r p drp |
---|---|
matchkey_str |
article:20538790:2022----::51naoapelnclvdneupriglccriodoeeutoadhsisuyein |
hierarchy_sort_str |
2022 |
callnumber-subject-code |
RC |
publishDate |
2022 |
allfields |
10.1136/lupus-2022-lupus21century.95 doi (DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e DE-627 ger DE-627 rakwb eng RC581-607 Victoria P Werth verfasserin aut 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Immunologic diseases. Allergy Eric F Morand verfasserin aut Melinda Przetak verfasserin aut Flavie Moreau verfasserin aut Cristina Vazquez-Mateo verfasserin aut Andrew Bender verfasserin aut Sanjeev Roy verfasserin aut Aditee Deshpande verfasserin aut Ankita Deshmukh verfasserin aut Bharat Vaidyanathan verfasserin aut Mukhy Khursheed verfasserin aut David R Pearson verfasserin aut In Lupus Science and Medicine BMJ Publishing Group, 2015 9(2022), Suppl 3 (DE-627)792128222 (DE-600)2779620-6 20538790 nnns volume:9 year:2022 number:Suppl 3 https://doi.org/10.1136/lupus-2022-lupus21century.95 kostenfrei https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e kostenfrei https://doaj.org/toc/2053-8790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 Suppl 3 |
spelling |
10.1136/lupus-2022-lupus21century.95 doi (DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e DE-627 ger DE-627 rakwb eng RC581-607 Victoria P Werth verfasserin aut 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Immunologic diseases. Allergy Eric F Morand verfasserin aut Melinda Przetak verfasserin aut Flavie Moreau verfasserin aut Cristina Vazquez-Mateo verfasserin aut Andrew Bender verfasserin aut Sanjeev Roy verfasserin aut Aditee Deshpande verfasserin aut Ankita Deshmukh verfasserin aut Bharat Vaidyanathan verfasserin aut Mukhy Khursheed verfasserin aut David R Pearson verfasserin aut In Lupus Science and Medicine BMJ Publishing Group, 2015 9(2022), Suppl 3 (DE-627)792128222 (DE-600)2779620-6 20538790 nnns volume:9 year:2022 number:Suppl 3 https://doi.org/10.1136/lupus-2022-lupus21century.95 kostenfrei https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e kostenfrei https://doaj.org/toc/2053-8790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 Suppl 3 |
allfields_unstemmed |
10.1136/lupus-2022-lupus21century.95 doi (DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e DE-627 ger DE-627 rakwb eng RC581-607 Victoria P Werth verfasserin aut 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Immunologic diseases. Allergy Eric F Morand verfasserin aut Melinda Przetak verfasserin aut Flavie Moreau verfasserin aut Cristina Vazquez-Mateo verfasserin aut Andrew Bender verfasserin aut Sanjeev Roy verfasserin aut Aditee Deshpande verfasserin aut Ankita Deshmukh verfasserin aut Bharat Vaidyanathan verfasserin aut Mukhy Khursheed verfasserin aut David R Pearson verfasserin aut In Lupus Science and Medicine BMJ Publishing Group, 2015 9(2022), Suppl 3 (DE-627)792128222 (DE-600)2779620-6 20538790 nnns volume:9 year:2022 number:Suppl 3 https://doi.org/10.1136/lupus-2022-lupus21century.95 kostenfrei https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e kostenfrei https://doaj.org/toc/2053-8790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 Suppl 3 |
allfieldsGer |
10.1136/lupus-2022-lupus21century.95 doi (DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e DE-627 ger DE-627 rakwb eng RC581-607 Victoria P Werth verfasserin aut 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Immunologic diseases. Allergy Eric F Morand verfasserin aut Melinda Przetak verfasserin aut Flavie Moreau verfasserin aut Cristina Vazquez-Mateo verfasserin aut Andrew Bender verfasserin aut Sanjeev Roy verfasserin aut Aditee Deshpande verfasserin aut Ankita Deshmukh verfasserin aut Bharat Vaidyanathan verfasserin aut Mukhy Khursheed verfasserin aut David R Pearson verfasserin aut In Lupus Science and Medicine BMJ Publishing Group, 2015 9(2022), Suppl 3 (DE-627)792128222 (DE-600)2779620-6 20538790 nnns volume:9 year:2022 number:Suppl 3 https://doi.org/10.1136/lupus-2022-lupus21century.95 kostenfrei https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e kostenfrei https://doaj.org/toc/2053-8790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 Suppl 3 |
allfieldsSound |
10.1136/lupus-2022-lupus21century.95 doi (DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e DE-627 ger DE-627 rakwb eng RC581-607 Victoria P Werth verfasserin aut 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Immunologic diseases. Allergy Eric F Morand verfasserin aut Melinda Przetak verfasserin aut Flavie Moreau verfasserin aut Cristina Vazquez-Mateo verfasserin aut Andrew Bender verfasserin aut Sanjeev Roy verfasserin aut Aditee Deshpande verfasserin aut Ankita Deshmukh verfasserin aut Bharat Vaidyanathan verfasserin aut Mukhy Khursheed verfasserin aut David R Pearson verfasserin aut In Lupus Science and Medicine BMJ Publishing Group, 2015 9(2022), Suppl 3 (DE-627)792128222 (DE-600)2779620-6 20538790 nnns volume:9 year:2022 number:Suppl 3 https://doi.org/10.1136/lupus-2022-lupus21century.95 kostenfrei https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e kostenfrei https://doaj.org/toc/2053-8790 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 9 2022 Suppl 3 |
language |
English |
source |
In Lupus Science and Medicine 9(2022), Suppl 3 volume:9 year:2022 number:Suppl 3 |
sourceStr |
In Lupus Science and Medicine 9(2022), Suppl 3 volume:9 year:2022 number:Suppl 3 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Immunologic diseases. Allergy |
isfreeaccess_bool |
true |
container_title |
Lupus Science and Medicine |
authorswithroles_txt_mv |
Victoria P Werth @@aut@@ Eric F Morand @@aut@@ Melinda Przetak @@aut@@ Flavie Moreau @@aut@@ Cristina Vazquez-Mateo @@aut@@ Andrew Bender @@aut@@ Sanjeev Roy @@aut@@ Aditee Deshpande @@aut@@ Ankita Deshmukh @@aut@@ Bharat Vaidyanathan @@aut@@ Mukhy Khursheed @@aut@@ David R Pearson @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
792128222 |
id |
DOAJ024830186 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ024830186</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307081025.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1136/lupus-2022-lupus21century.95</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ024830186</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Victoria P Werth</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Eric F Morand</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Melinda Przetak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Flavie Moreau</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cristina Vazquez-Mateo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Andrew Bender</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanjeev Roy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aditee Deshpande</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ankita Deshmukh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bharat Vaidyanathan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mukhy Khursheed</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David R Pearson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Lupus Science and Medicine</subfield><subfield code="d">BMJ Publishing Group, 2015</subfield><subfield code="g">9(2022), Suppl 3</subfield><subfield code="w">(DE-627)792128222</subfield><subfield code="w">(DE-600)2779620-6</subfield><subfield code="x">20538790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:Suppl 3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1136/lupus-2022-lupus21century.95</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2053-8790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2022</subfield><subfield code="e">Suppl 3</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Victoria P Werth |
spellingShingle |
Victoria P Werth misc RC581-607 misc Immunologic diseases. Allergy 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
authorStr |
Victoria P Werth |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)792128222 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC581-607 |
illustrated |
Not Illustrated |
issn |
20538790 |
topic_title |
RC581-607 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
topic |
misc RC581-607 misc Immunologic diseases. Allergy |
topic_unstemmed |
misc RC581-607 misc Immunologic diseases. Allergy |
topic_browse |
misc RC581-607 misc Immunologic diseases. Allergy |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Lupus Science and Medicine |
hierarchy_parent_id |
792128222 |
hierarchy_top_title |
Lupus Science and Medicine |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)792128222 (DE-600)2779620-6 |
title |
1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
ctrlnum |
(DE-627)DOAJ024830186 (DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e |
title_full |
1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
author_sort |
Victoria P Werth |
journal |
Lupus Science and Medicine |
journalStr |
Lupus Science and Medicine |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
txt |
author_browse |
Victoria P Werth Eric F Morand Melinda Przetak Flavie Moreau Cristina Vazquez-Mateo Andrew Bender Sanjeev Roy Aditee Deshpande Ankita Deshmukh Bharat Vaidyanathan Mukhy Khursheed David R Pearson |
container_volume |
9 |
class |
RC581-607 |
format_se |
Elektronische Aufsätze |
author-letter |
Victoria P Werth |
doi_str_mv |
10.1136/lupus-2022-lupus21century.95 |
author2-role |
verfasserin |
title_sort |
1501 enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase ii study design in patients with sle and/or cle (willow) |
callnumber |
RC581-607 |
title_auth |
1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
Suppl 3 |
title_short |
1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) |
url |
https://doi.org/10.1136/lupus-2022-lupus21century.95 https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e https://doaj.org/toc/2053-8790 |
remote_bool |
true |
author2 |
Eric F Morand Melinda Przetak Flavie Moreau Cristina Vazquez-Mateo Andrew Bender Sanjeev Roy Aditee Deshpande Ankita Deshmukh Bharat Vaidyanathan Mukhy Khursheed David R Pearson |
author2Str |
Eric F Morand Melinda Przetak Flavie Moreau Cristina Vazquez-Mateo Andrew Bender Sanjeev Roy Aditee Deshpande Ankita Deshmukh Bharat Vaidyanathan Mukhy Khursheed David R Pearson |
ppnlink |
792128222 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1136/lupus-2022-lupus21century.95 |
callnumber-a |
RC581-607 |
up_date |
2024-07-04T00:33:01.430Z |
_version_ |
1803606484773240832 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ024830186</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307081025.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1136/lupus-2022-lupus21century.95</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ024830186</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ5c3258c0b9b64cb9a1d92d3d8248015e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-607</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Victoria P Werth</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Immunologic diseases. Allergy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Eric F Morand</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Melinda Przetak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Flavie Moreau</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Cristina Vazquez-Mateo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Andrew Bender</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanjeev Roy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Aditee Deshpande</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ankita Deshmukh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bharat Vaidyanathan</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Mukhy Khursheed</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">David R Pearson</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Lupus Science and Medicine</subfield><subfield code="d">BMJ Publishing Group, 2015</subfield><subfield code="g">9(2022), Suppl 3</subfield><subfield code="w">(DE-627)792128222</subfield><subfield code="w">(DE-600)2779620-6</subfield><subfield code="x">20538790</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:Suppl 3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1136/lupus-2022-lupus21century.95</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/5c3258c0b9b64cb9a1d92d3d8248015e</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2053-8790</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">2022</subfield><subfield code="e">Suppl 3</subfield></datafield></record></collection>
|
score |
7.3985224 |